×

You're seconds away from this technical note!

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.
Thank you!
Error - something went wrong!
   

Fast expression screening that reveals expression levels of properly folded recombinant proteins

Protein expression and production teams in the pharmaceutical industry, CROs, and other protein service providers spend a lot of time and resources trying to identify the optimal conditions for high expression levels of recombinant protein. The process is generally tedious and inefficient, often driven by trial and error, especially for novel targets. It’s clear that knowing early on if a recombinant protein is not only highly expressed but also structurally stable would make protein production teams more efficient by lowering cost, providing actionable insights at the small-scale stage, and allowing faster hand-over of high-quality proteins to clients or teams downstream. This case study compares the evaluation of expression conditions of His-tagged HRV3C protease expressed in E.coli using data from traditional SDS-PAGE and the Andromeda system.

Previous
Quickly screen for optimal  expression levels and  thermal stability for your toughest membrane proteins
Quickly screen for optimal expression levels and thermal stability for your toughest membrane proteins

Up next
NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins
NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins

SOUTH SAN FRANCISCO, Calif. June 24, 2021 — NanoTemper Technologies, well-known for creating biophysical to...

Have a question about Andromeda?

Contact Specialist